The acceptability and cost of a home-based chlamydia retesting strategy: findings from the REACT randomised controlled trial

Table 5 Cost per infection of home and clinic retesting

Trial arm	Retest uptake	n	%	Cost of retest component $	Cost of overall retest pathway $	Overall cost $	No. of repeat infections	Cost per repeat infection $
Clinic retest	No retest	181	61		98.7^a	17864.7
	Retest	117	39	69.9	168.6	19726.2
	Total	298				37590.9	12	3132.6
Home retest REACT study	No retest	118	39		116.4^b	13735.2
	Retest at home	134	44	55.3	154.0	20636.0
	Sent home kit but retested at the clinic	50	17		186.3^c	9315.0
	Total	302				43686.2	31	1409.2

^aIncludes all costs in the clinic retest pathway except the retest component
^bIncludes all costs in the home retest strategy except the laboratory fee
^cIncludes all costs in the home retest strategy except the laboratory fee, plus the cost of the clinic retest component

ISSN: 1471-2458